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Abstract
The term edema-likemarrow signal intensity (ELMSI) represents a general term describing an area of abnormal signal intensity at
MRI. Its appearance includes absence of clear margins and the possibility of exceeding well-defined anatomical borders (for
example, physeal scars). We can define “ELMSI with unknown cause” an entity where the characteristic MR appearance is
associatedwith the absence of specific signs of an underlying condition. However, it is more often an important finding indicating
the presence of an underlying disease, and we describe this case as “ELMSI with known cause.” It presents a dynamic behavior
and its evolution can largely vary. It initially corresponds to an acute inflammatory response with edema, before being variably
replaced by more permanent marrow remodeling changes such as fibrosis or myxomatous connective tissue that can occur over
time. It is important to study ELMSI variations over time in order to evaluate the activity state and therapeutic response of an
inflammatory chronic joint disease, the resolution of a trauma, and the severity of an osteoarthritis. We propose a narrative review
of the literature dealing with various subjects about this challenging topic that is imaging, temporal evolution, etiology, differ-
ential diagnoses, and possible organization, together with a pictorial essay.




ELMSI Edema-like marrow signal intensity
RA Rheumatoid arthritis
SIFK Subchondral insufficiency fractures of the knee
STIR Short T1 inversion recovery
Introduction
The term edema-likemarrow signal intensity (ELMSI) represents
a general term describing an area of abnormal signal intensity (SI)
at MRI [1]. Currently, the term “ELMSI” replaces the old term
“bone marrow edema,” which more properly represents a histo-
pathological diagnosis, with the finding of an eosinophilic bone
marrow extracellular fluid and swollen fat cells [1].
These areas of abnormal SI appear in very different condi-
tions and are caused by various physiological and pathological
processes. This SI alteration is usually caused by a patholog-
ically detectable edema but can be also induced by medullary
necrosis or blood products collection [1].
In fact, while MRI is well able to evaluate the evolution of
heme-catabolic products, it does not easily distinguish cell
swelling from the simple accumulation of extracellular fluids,
or inflammation from fresh granulation tissue. So, what we
define ELMSI is a non-specific but important finding usually
indicating the presence of an underlying disease that can be
found in many different pathological conditions (“ELMSI
with known etiology”). Conversely, when it is found at MRI
as an isolated finding without obvious cause, we can define it
as “ELMSI with unknown etiology” [2, 3].
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Based on this assumption, ELMSI has different implica-
tions in diverse diseases. Our aim was to highlight these var-
iances and to propose a narrative review of the literature to-
gether with a pictorial essay trying to enhance the dialogue
between clinicians and radiologists.
Imaging
Clinical standard
MRI is ideal for localizing the increased extracellular water of
ELMSI and for the differential diagnosis of the associated
disease [4, 5]. ELMSI appearance includes the absence of
clear margins and the possibility of exceeding well-defined
anatomical borders (for example, physeal scars) [4, 6].
It shows a low SI on T1-weighted (T1w) imaging and a
high SI on T2-weighted (T2w, in particular if fat-suppressed)
and on short T1 inversion recovery (STIR, another sequence
adopted to saturate the signal of fat tissues) imaging [7].
Usually, after contrast agent administration [6, 8, 9], the en-
hancement is intense, and the SI even higher than on fat-
suppressed and STIR acquisitions [9]. ELMSI develops from
the periphery of a space-occupying lesion and it can be very
complicated to differentiate it from the mass [10]. A further
problem is given by the differentiation of ELMSI related to a
malignancy compared to one related to a benign form: in
recent years, this problem has been partially solved thanks to
the adoption of diffusion-weighted imaging (DwI) and chem-
ical shift-weighted imaging [11–13]. In fact, DwI with low b
value allows to distinguish ELMSI caused by a vertebral frac-
ture (trace, isointense vs.. normal marrow; apparent diffusion
coefficient (ADC), high value) from that caused by a metasta-
tic tumor infiltration of the spine (trace, hyperintense vs. nor-
mal marrow; ADC, low value) [14]. The enhancement pattern
can help predict the evolution and the histopathological char-
acteristics of ELMSI: a study differentiated ELMSI patterns in
edema-like lesions, with a complete homogenization after
contrast agent intravenous administration, and necrosis-like
lesions, which showed incomplete and inhomogeneous en-
hancement [15]. At histopathological level, edema-like le-
sions were sustained by edema with accumulation of eosino-
philic extracellular fluid into trabecular spaces at the periphery
of the lesion; conversely, necrosis-like lesions were character-
ized by bone marrow fibrosis with necrosis areas, prevalently
central.
Research activity
STIR and T2w fat-suppressed images are very sensitive to
detect ELMSI, but permit only a visual assessment [16], while
DwI allows both qualitative and quantitative evaluations,
which are helpful to better define the amount of cellular
crowding or to give an estimate of the inflammatory degree
[17]. The possibility of the latter assessment could be very
helpful, especially in diseases as rheumatoid arthritis or anky-
losing spondylitis, where patients’ stratification it very impor-
tant for the individualized therapy and to predict disease pro-
gression. Even if to date there are no validated protocols for a
universally recognized and confident ELMSI quantification,
there are some promising sequences, such as IDEAL (i.e.,
iterative decomposition of water and fat SI with echo asym-
metry and least squares estimation), based on multipoint
Dixon fat water separation principle. The rationale is to ensure
a uniform separation of water and fat, while providing images
with a high signal-to-noise ratio. In fact, an optimal fat sup-
pression could help develop a semi-automatic method for a
correct quantitative assessment of ELMSI [18].
Perfusion-weighted imaging (PwI) was adopted as well in
the attempt to give a prognostic assessment of ELMSI and to
explain the related phenomena. The rate of contrast agent
elimination was lower in ELMSI areas than in the unaffected
bone, thus suggesting a venous obstruction blocking the out-
flow [19]. A significant correlation between ELMSI area di-
mension and the rate of contrast agent elimination was found,
in patients with knee osteoarthritis in which perfusion param-
eters were investigated on PwI-MRI [20]. These results sug-
gest that venous stasis could cause an intraosseous hyperten-
sion and consequently reduced perfusion and hypoxia. This
mechanism could be responsible, at least in part, not only for
pain but also for osteocyte stimulation and consequently bone
remodeling [19]. Perfusion studies could be helpful in the
differential diagnosis of three conditions characterized by
ELMSI in the acute phase, but with great differences in terms
of treatment and clinical outcome: transient osteoporosis of
the hip, avascular necrosis (AVN), and subchondral insuffi-
ciency fractures (SIF) of the femoral head. Transient bone
osteoporosis of the hip is usually spontaneously self-limited,
AVN represents an irreversible condition possibly leading to
permanent joint failure, and SIFmay either completely resolve
or progress towards osteonecrosis. Either conventional MRI
acquisition or DwI does not always allow to differentiate these
conditions [21, 22], but significant differences are found in
perfusion parameters: maximum enhancement showed higher
values in the transient osteoporosis and SIF, than in the AVN
group. These higher values are maybe caused by reperfusion
phenomena [23] that characterize transient osteoporosis and
SIF, while the lower values in AVN are probably due to in-
flammatory processes, fibrocystic repair [24], and granulation
tissue adjacent to the necrotic marrow [25]. Even if the co-
presence of transient osteoporosis and SIF is not a univocal
pattern [26], the differences in PwI reported above confirm
that these conditions can be different spectra of the same dis-
ease [27].
Is it possible to detect a pattern equivalent to ELMSI by
other acquisition techniques? While this detection by single
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energy CT has always been arduous due to the overlaying
trabecular structure, dual-energy (DE-CT) techniques resulted
able to discriminate water and fat, allowing the recognition of
CT-pattern with value comparable to ELMSI. Moreover, vir-
tual non-calcium DE-CT can visualize the marrow alterations
in osteoporotic patients with acute vertebral fractures, helping
to differentiate the older fractures from the recent ones [28]
and DE cone-beam CT allows the detection of bone marrow
edema and quantification of water and fat content in extrem-
ities [29].
ELMSI as physiological finding
ELMSI is not always a pathological finding and may be
observed in healthy children, where it is generally a tem-
porary, self-limiting condition, particularly in the knee.
Here, a focal peripheral edema at the growth plate is usu-
ally detectable, sometimes associated with pain. This is
attributed to early stages of growth plate closure. A local
ELMSI can be found in children during rapid growth at the
spine too, as a transient finding decreasing over time, not
related to physical activity. Other common frequent sites
are the epi- and metaphysis of the distal femur, proximal
tibia/fibula [30, 31], and at carpal bones/wrists [32, 33]. In
these settings, ELMSI does not require invasive diagnostic
procedures or imaging follow-up. Probable mechanisms
include formation of metaplastic bone-neo-fibrocartilage,
diminution in bone elasticity [31], local vascular alter-
ations, and bone microtraumas [34].
ELMSI of the sacroiliac joints is another physiological
condition and a very common finding in women screened
for lower back pain. These marrow signal alterations have a
predilection for the lower part of sacroiliac joint where stron-
ger shear forces act, due to the increased weight carried in the
anterior pelvis and the lordotic posture assumed by the moth-
er. On the other hand, ELMSI of these joints represents a
hallmark of axial spondyloarthropathies and the radiologist
must not make the mistake of diagnosing these rheumatolog-
ical diseases in peripartum women. The problem of misdiag-
nosis is real, considering that a significant proportion of these
women with a physiologic ELMSI in the early period after
l abo r fu l f i l l t he c r i t e r i a o f the Asses smen t o f
SpondyloArthritis International Society (ASAS) of a positive
MRI for sacroiliitis, but these findings (and scores) decrease
over time in the majority of the cases. For this reason, when an
axial spondyloarthropathy is suspected, it is reasonable to wait
at least 6 months to perform an MRI in postpartum women,
and, if positive, repeat the exam after 12 months. The evolu-
tion of this physiological condition towards a true
spondyloarthropathy seems coincidental, since the prevalence
of peripartum women with ELMSI of the sacroiliac joints is
not far greater than would be expected in a young patient
population (< 4%) [35, 36].
Also, the phenomenon of conversion of the red marrow
into yellow one is a physiological process and should not
to be confused with the related ELMSI phenomena. Red
and yellow bone marrows have different chemical compo-
sition. The first contains 40% fat, 40% water, and 20%
protein, while the second one has 80% fat, 15% water,
and 5% protein. The most sensitive sequences used for
imaging of bone marrow changes are the GE in/opposed
phase, when the H protons linked to water and fat are in the
same voxel, and fat sat (STIR/SPIR/SPAIR) when the H
protons linked to water and fat are in adjacent but different
voxels. This is important to exclude the possible areas of
ELMSI, which has a proportion of water protons higher
than that of red marrow, and so a higher SI in T2w acqui-
sition fat sat. The same acquisitions are important in the
study of the reversal process too, i.e., bone marrow recon-
version (from yellow to red marrow). This is a physiolog-
ical response to increased hematopoietic needs of the body,
including non-medical conditions, as can happen in “heavy
smokers” or persons doing sports with a large oxygen
need, and medical conditions, such as obesity (and related
respiratory disorders), diabetes, anemia, and patients treat-
ed with hematopoietic growth factors [37].
ELMSI temporal evolution
ELMSI presents a dynamic behavior [38, 39]: it goes through
remodeling processes and its within-time evolution could
largely vary at MRI study [40]. In the acute phase of an oste-
itis, ELMSI is mainly supported by edema but, in the subse-
quent phases of inflammation, bone marrow will undergo a
remodeling process and ELMSI causative factors can be fi-
brosis or myxomatous connective tissue. For this reason, the
medullary SI of the initial phases of inflammation (high water
content) will be very different from the SI of the late phases
(low water content) since ELMSI itself could vary in water
content and size [40].
ELMSI can undergo dimensional and SI fluctuations
over time, especially depending on the activity/inactivity
phase of the underlying disease, but these variations are not
always associated with clinical changes. In osteoarthritis,
ELMSI is a frequent finding, often fluctuating over a long-
time period but the ELMSI dimensional reduction is not
related with a decrease in the pain felt by the patient, val-
ued via Western Ontario and McMaster Universities
Arthritis Index (WOMAC) questionnaires [41]. The corre-
lation between ELMSI evolution and the pain felt appears
stronger in patients with transient knee osteoporosis [42],
where a reduction in size of the edema is related to a re-
duction in the activity pain [42]. A classic example of such
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dynamic behavior of ELMSI are the so-called Modic
changes, vertebral body endplate SI alterations often de-
tectable in the MRI study of degenerative disk disease and
spondylosis. These findings were first reported by de Roos
[43] while Modic [44] gave the classification of these SI
changes, as follows:
– Type I (SI low in T1w, high in T2w) corresponds to body
edema and hypervascularity (Fig. 1)
– Type II (SI high in T1w, high in T2w) is a fatty infiltration
of the bone marrow (Fig. 2).
– Type III (Si low SI in T1w, low in T2w) consists of
subchondral sclerosis [45] and is rarer (Fig. 3).
The clinical importance of Modic changes is uncertain
but it was hypothesized that Modic I alterations are relat-
ed to the patient’s low back pain [46]. In fact, Modic I
changes are associated with endplate neovascularity that
would trigger vertebral nociceptors located precisely at
this level (like those in the annulus fibrosis and posterior
longitudinal ligaments).
Fig. 1 a, b Degenerative. Modic
changes type I in a 78-year-old
woman with back pain. MRI
shows the SI alterations in D11
and D12 endplates (arrows), that
appear hypointense on T1w (a)
and hyperintense on T2w (b) im-
aging. These alterations corre-
spond to vertebral body edema
and hypervascularity
Fig. 2 a, b Degenerative. Modic
changes type II in a 53-year-old
man. The hyperintense SI on T1w
imaging of two lumbar bordering
endplates (arrows in a) and hy-
perintense SI on T2w imaging
(arrows in b) reflects fatty re-




Histopathological findings in ELMSI
The MRI pattern of ELMSI is caused by various occurrences
related to a replacement of normal fatty bone marrow by a
more water-rich tissue [47]. This change was often assumed
to be due to a real local edema, but only few studies confirm
this hypothesis [48]. On the contrary, as we have seen above,
in most histological samples, it was found prevalently lym-
phocytic infiltrates, fibrosis, improved vascularization, and
reduced mineralized bone. These findings, however, should
be considered with caution due to inevitable limitations relat-
ed to the time passed between ELMSI appearance and histo-
logical examination. To summarize the occurrences found in
literatures, the histopathological meaning of ELMSI could be
different in distinct clinical entities, as follows:
1 A simple real edema and a reduced bone mineralization in
transient osteoporosis; these are usually self-limiting and re-
cover in a variable time, without sequelae in most cases [49].
2 A leakage of interstitial fluid and hemorrhage into marrow
spaces [8], as consequence of acute or chronic repeated
traumas inducing marrow trabeculae disruption.
3 An inflammatory infiltrate in rheumatoid arthritis (RA); in
this case, the edema can be mediated by local cytokines
related to trauma and hypoxia. The local release of pro-
inflammatory cytokines in the presence of an inflammato-
ry infiltrate has been documented in inflammatory arthritis
such as RA, where bone marrow fat is replaced by aggre-
gates of lymphocytes and blood vessels [47].
4 A fibrosis and bone marrow necrosis in advanced
osteoarthritis.
5 A vascular alteration as an increased marrow blood flow
(hyperemic) or an impaired vascular drainage (congestive)
[8]; both conditions can cause an increased intraosseous
pressure which can lead to a diminished perfusion and
hypoxia [19].
Etiology and organization
There is still a poor understanding of the pathological mech-
anisms underlying ELMSI. The most recognized mechanism,
the “bone insult cascade,” which determines its onset and
possible evolution towards resolution or osteonecrosis is sum-
marized (Fig. 4) and an adapted classification according to
putative risk factors is reported (Table 1). For a radiologist,
the earliest moment linked to ELMSI is obviously its recog-
nition; consequently, it is important to figure out the patho-
logical process by trying to subcategorize EMLSI as “with
known cause” and “with unknown cause.” The latter category
should only be diagnosed once every possible underlying
cause has been excluded. The various etiological subcate-
gories will be discussed in detail in the following sections,
according to the best-known classification [54].
Fig. 3 a, b, c Degenerative. Modic changes type III in a 53-year-old
woman. The hypointense SI areas (arrows) both on T1w (A) and T2w
(B) imaging reflect a subchondral bone sclerosis. The lumbosacral spine
x-ray of the same patient (C) allows to better observe the bone sclerosis
(arrow) of the caudal lumbar spine (courtesy of Giacomo Aringhieri,
MD, University of Pisa School of Medicine, Italy)
Normal bone
Various types of bone insult
Bone alteration
(as focal turnover increment, higher intraosseous pressure, stress, 
microfractures)
Edemalike marrow signal intensity (possible compartment syndrome)
Reparative attempts
Adequate                      Inadequate                          
Gradual resolution              Bone necrosis
Fig. 4 Bone insult cascade. Adapted from references [50, 51]
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Table 1 Classification of ELMSI with known etiology, adapted from references [52, 53]
Type Etiology Main imaging features
Trauma Direct or indirect damage,
fracture, CRPS
- The stress injury-induced ELMSI is often subchondral and wedge-shaped
with the base located at the site of greatest stress
- The bone bruise/contusion appears as an area of heterogeneous ELMSI
- ELMSI is larger if due to compressive rather than traction forces
- If a fracture is present, ELMSI is accompanied by the hypointense line in all
sequences
- The CRPS-induced ELMSI typically shows a patchy pattern
Trauma/degenerative SIF - Ill-defined ELMSI arising from the subchondral region with a fracture line
in the subarticular marrow
- Ischemic low T2w-SI subchondral area subjacent to the collapsed bone plate
- Fluid-filled cleft underlying the collapsed bone plate
Degenerative Osteoarthritis - Joint-sited ELMSI due to high metabolic activity, extracellular matrix
turnover/angiogenesis, and bone formation
- ELMSI is frequently associated with geodes, reactive synovitis, joint
effusion and loss of joint space
- More evident ELMSI when greater cartilage loss or abnormalities occur
Degenerative/inflammatory Modic changes - Type I (low SI in T1w and high SI in T2w) corresponds to vertebral body
edema and hypervascularity
- Type II (high SI in T1w and T2w) reflects fatty replacements of the red BM
- Type III (low SI in T1w and T2w) consists of subchondral bone sclerosis
Inflammatory Inflammatory arthritis, enthesitis - ELMSI is caused by the replacement of the medullary fat with inflammatory
cells with edema
- Immature blood vessels containing high levels of VEGF can also contribute
to ELMSI appearance
- In RA patients, ELMSI is representative of bone inflammation, initially
located in the bare areas
- In these patients ELMSI and synovitis precede the appearance of bone
erosion and joint space narrowing and
- The progression of joint destruction is significantly greater in ELMSI
positive rather than in negative joints
Vascular Avascular necrosis (AVN) - ELMSI is sited in the viable tissue and surrounds the area of necroticmarrow
outlined by a low SI rim
- This rim is often double-lined on T2w acquisitions: a high inner (granulation
tissue) and an outer low SI band (sclerosis)
- AVN-related ELMSI seems not to represent an early finding and could be
secondary to a subchondral fracture
Infectious Bone and articular infections - ELMSI frequently surrounds a mass of infected tissue
- Septic arthritis has a wide spectrum of imaging presentation and can be
divided in:
- Necrotic, caused by an ischemic mechanism
- Exudative, induced by vascular congestion (DD with gelatinous
transformation of bone marrow, due to protein loss)
Neoplastic Benign lesions - Benign lesions as osteoid osteoma and osteoblastoma show an important
ELMSI
- Usually ELMSI seems caused by trabecular destruction and local
inflammation, but
- Osteoid osteoma surrounding ELMSI seems due to tumor-associated in-
flammatory mediators (PGE2)
Neoplastic Malignant lesions - Generally, primary/secondary malignancy induces a minor quantity of ELM
with respect to benign tumors but
- Chondroblastoma and Langerhans’s cell histiocytosis are surrounded by an
intense ELMSI
-DwI can differentiate the neoplastic focus from the surrounding ELMSI
Iatrogenic After surgery or RT, steroids or calcineurin
inhibitors
- ELMSI RT-related is the most frequent
- In this case usually presents fast onset and short duration (1-14-day time
frame), however




Edema-like marrow signal intensity with unknown
cause
This category can include all those diseases characterized by
ELMSI as a main, often unique, sign and whose etiology is
not defined, as “transient bone marrow edema syndrome,”
“transient regional osteoporosis,” “transient regional bone
marrow edema,” “migratory osteoporosis” [54]. In the past,
depending on the medical specialist involved (rheumatologist,
orthopedic, or radiologist), the use of different terms to specify
the same condition (for example, “transient regional osteopo-
rosis” or “transient regional bone marrow edema”), has led to
some misunderstandings as to what exactly was meant [55].
Unfortunately, it is not possible to assert that it is always
spontaneously resolving: the cases of ELMSI with unknown
etiology are too few to reach this conclusion and there are
some possible cases of transient edema syndrome that have
progressed towards osteonecrosis [56]. On this background,
we could define primary ELMSI as a usually self-limiting
condition with unknown etiology, resolving without long-
term sequelae and/or necessity of surgical treatment [54],
which may migrate to involve another bone in a same region
or a distant bone in the same or contralateral limb. As being
understandable, only an “a posteriori diagnosis” is feasible
[55] (Fig. 5). The best known of these disorders is the transient
osteoporosis of the hip, a disorder most common in young
men and women in the last trimester of pregnancy, predispos-
ing them to fragility fractures. The SI alteration is usually
located at the femoral head and may extend to the femoral
neck and intertrochanteric region and is often accompanied
by joint effusion. The delayed peak enhancement of edema-
tous marrow is characteristic of this condition [57].
Edema-like marrow signal intensity with known cause
Trauma It represents one of the most important and frequent
mechanisms in determining ELMSI. The traumatic mecha-
nisms underlying its onset are manifold (biomechanical stress
injury, bone bruise/contusion, fracture) and MRI can help in
identifying them (Fig. 6). The stress injury–induced ELMSI is
often subchondral and wedge-shaped, with the base located at
the site of greatest stress or load; the bone bruise/contusion
appears as an area of heterogeneous marrow alteration, larger
if it is due to compressive forces rather than traction forces; in
a fracture, it is accompanied by the presence of the
hypointense line in all sequences [58]. Also, especially in
the knee, ELMSI is statically linked to many ligament and
meniscal injuries, so its presence can be helpful to focus at-
tention on subtle but important abnormalities that might oth-
erwise be missed, such as popliteo-fibular ligament damage
and meniscal [59].
The etiology of ELMSI caused by subchondral insufficien-
cy fractures of the knee (SIFK, which replaces the old term
spontaneous osteonecrosis of the knee, SONK) can be consid-
ered, in part, traumatic as linked to these micro-fractures in the
porotic bone. SIFK is at present known to be caused by insuf-
ficiency fractures, with fluid accumulation in the bone mar-
row, subsequent edema with focal ischemia, and eventual ne-
crosis, however rarely observed [60]. SIFK are typically uni-
lateral, most seen in 60-year-olds or older women [61] and are
classically described as focal, superficial subchondral lesions,
mainly affecting the medial femoral condyle [62]. A strong
association between meniscal tears, particularly of the medial
posterior root, and SIFK has been recently observed [60],
probably due to the consequent increased contact pressures.
MRI features of SIFK include an ill-defined ELMSI in the
subchondral region, the hypointense rhyme of fracture with
the collapse and separation of the bone plate [62–64], and a
subchondral area of low SI on T2w located immediately sub-
jacent to the bone plate. This area, representing local ischemia,
is very important because if it is thicker than 4 mm or longer
than 14 mm, the lesion may be irreversible and may evolve
into irreparable epiphyseal collapse and articular destruction.
For this reason, this area acts as the most important prognostic
indicator of more rapidly progressive lesion [65, 66].
Unfortunately, ELMSI does not appear to have a prognostic
role in prediction of poor clinical outcome because diffuse
marrow changes can be observed in the early stages of irre-
versible osteonecrosis and in transient lesions as well.
Furthermore, no correlation with the ELMSI extension has
Table 1 (continued)
Type Etiology Main imaging features
Hydroxyapatite deposition disease, CPPD,
gout
- ELMSI is due to the inflammatory response at pathologic tendon insertion
site
- This reaction is due to hydroxyapatite or calcium pyrophosphate deposition
- In gout can be caused by the presence of intraosseous tophi
Neurological Charcot’s joints - ELMSI is often associated with this disorder commonly affecting foot and
ankle
- ELMSI is an early sign of Charcot’s joint
- MRI is sensitive to follow the course of the healing process and differentiate
acute Charcot’s foot from acute osteomyelitis
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been observed [65, 67]. In the acute phase after pain onset,
ELMSI increases both in intensity and extension and a small
subchondral sclerosis could appear on T1w imaging, while
radiography remains unremarkable. If the condition is recog-
nized and properly treated, in the following weeks, MRI will
show subtotal regression of marrow alterations and over the
next fewmonths the lesionwill continue to decline, but chang-
es could remain even after 2.5 years [68]. ELMSI from com-
plex regional pain syndrome (CRPS) (Fig. 7) can be included
in this category. CRPS can develop secondary to any trauma,
and is characterized by a continuing (spontaneous and/or
evoked) regional pain that is disproportionate in time or de-
gree to the usual course of any known trauma or other lesion
and is believed to be caused by damage to, or malfunction of,
the autonomic nervous system. Typical MRI findings are
patchy ELMSI and diffusely increased juxta-articular fluid
[69].
Degenerative The MRI presentation of osteoarthritis includes
geodes, reactive synovitis, joint effusion, osteophytes, loss of
joint space, and subchondral ELMSI. The edema is more fre-
quent in those patients who have greater cartilage loss or
abnormalities [58]. Symptoms of impaired function in osteo-
arthritis are influenced not only by joint synovitis and effu-
sion, tendon, and ligament involvement but also by the pres-
ence of ELMSI, which represents regions of high metabolic
activity with increased extracellular matrix turnover, angio-
genesis, and bone formation [70]. Although a precise statisti-
cal correlation between its extension and pain has not been
proved yet [41], multiple studies have observed this relation-
ship. Ahedi [71] found that the presence of large hip ELMSI in
osteoarthritis patients was associated with overall fourfold
higher odds of hip pain and that an increase in hip ELMSI
size over time was related to a progressive increase in pain.
Furthermore, a high cartilage signal, reflecting deleterious
changes in articular cartilage, may be asymptomatic because
it is not directly related to pain, although it is strongly associ-
ated with the presence of large hip marrow alterations (most
notably acetabular) [71]. Unfortunately, the studies correlating
the extent of ELMSI and joint pain are too few and further
studies are needed in the future to clarify a precise correlation.
In this context, we should not forget the Modic changes,
which can contribute to evaluate the spinal degenerative dis-
ease (Figs. 1, 2, 3).
Fig. 5 a, b, c, d Primary. A 53-
year-old male patient with pain,
swelling, and stiffness of the left
knee. STIR imaging from the first
MRI exam (a, b) highlights edema
(A single asterisk (*) in a and ar-
rowheads in b) in the medial
condyle; degenerative phenome-
na affecting meniscuses, articular
cartilage and ligaments are not
present. STIR imaging performed
after two months (c, d) shows that
edema (*), from the medial com-
partment of the knee, has moved
into the lateral compartment of
the same knee, while all the other
findings observed at the first ex-
amination remained unchanged.
Every possible etiology has been
excluded: this is an example of
migratory primary ELMSI
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Inflammatory ELMSI can be observed in many musculoskel-
etal inflammatory pathologies as RA (Fig. 8): in this case, it is
a product of bone inflammation, consisting in the replacement
of the medullary fat with a cellular infiltration leading to an
increase in the local water content and edema. According to
one of the most accredited theories, ELMSI is initially located
in the “bare areas,” regions of bone that are uncovered by
cartilage, where the pannus, which is a hyperplastic synovium
filled with inflammatory cells and dilated vessels, acts on the
underlying marrow [58, 72]. ELMSI appears after a few
weeks from occurrence of symptoms and correlates with ele-
vated markers of acute inflammatory phase; furthermore, it is
a reversible phenomenon and may become attenuated due to
biological treatment [73]. As with RA, it also intervenes in the
pathogenesis of other rheumatological conditions, such as in-
flammatory arthropathies in general and systemic diseases
causing chronic inflammation and fibrosis [58]. In RA pa-
tients, ELMSI is a common finding, most frequently in the
upper extremities but described in all possible locations of
disease; it can be found already from the early stages of RA,
but it could arise even later. American College of
Rheumatology/European League Against Rheumatism
(ACR/EULAR) guidelines suggest the use of ultrasound in
early RA to assess the activity of the inflammation with re-
spect to MRI, that is reserved for a small portion of clinically
difficult cases and clinical studies. So, in these patients, the
study of ELMSI seems less important than the findings visible
with ultrasound [74]. Taking this into consideration, we must
however recognize the information that ELMSI can provide
once it has been observed in a RA patient: the detection of
synovitis and ELMSI allows the aggressive forms of RA to be
recognized earlier because bone erosion and joint space
narrowing are invariably preceded by these phenomena.
Moreover, the progress of joint destruction is significantly
greater in ELMSI positive rather than in ELMSI-negative
joints [75]. Many studies recognize the presence of ELMSI
as the strongest individual predictor of bone erosions. Other
factors such as the RAMRI score (RAMRIS) for synovitis, C-
reactive protein, and anti-cyclic–citrullinated peptide status
did not achieve a comparable predictive significance
[76–83]. The risk of forming erosions is 6-fold higher in areas
where ELMSI was noted earlier [73]. Moreover, if it was once
thought that erosions only developed in joints where synovitis
was and hampered in the joints where synovitis had been
Fig. 6 a, b, c, d Traumatic. A 17-
year-old female with a traumatic
ELMSI after a contusion of the
right knee. STIR coronal imaging
(a, b) demonstrates the presence
of the hyperintense ELMSI (*) in
the anterior side of the lateral
femoral condyle (a) and in the
lateral side of the tibial plateau
(b). The presence of an abundant
marrow signal alteration is often
correlated with a ligament injury:
in this case, the anterior cruciate
ligament (ACL) is scarcely rec-
ognizable (arrows) both in the
T1w (c) and T2w (d) sequences:
the finding is compatible with a
high-grade ACL injury
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suppressed [84], McGonagle [85] has observed progression
towards erosion formation in joints without clear MRI traits
of synovitis. In these patients, it was only possible to observe a
very slight thickening of the synovium but, above all, abun-
dant marrow alterations. It is thought that synovitis does not
directly cause erosions, but rather indirectly induces them
through ELMSI: inflammation of bone marrow causes the
migration of inflammatory mediators and cells into the joint
cavity through enlarged channels within bone tissue, leading
to synovitis and, in an indirect manner, to erosion formation.
In this model, ELMSI would appear earlier than synovitis
[73]. Furthermore, it may be a more sensitive and earlier
indicator of the response to therapy than appearance of the
synovium thickening [73]. In patients receiving anti-TNF-α
therapy, there is a significant reduction in OMERACT
(OutcomeMeasures in Rheumatology) scores both of synovi-
tis and ELMSI with significantly less erosive progression at 1
year, but the reduction of the latter occurs earlier (1 month vs.
3 months) [73]. ELMSI is also the most important predictor of
progression to criteria-positive RA in patients with undiffer-
entiated arthritis, both independently and to a greater extent
when combined with anti-cyclic–citrullinated peptide status or
rheumatoid factor positivity [86]. In the earlier phases of the
disease, it is usually located in the subchondral bone, well seen
Fig. 7 a, b, c, d Traumatic
(CRPS) and iatrogenic. A 58-
year-old woman that underwent
surgery for left hallux valgus cor-
rection. All the figures are STIR
images. Panels a and b come from
the first exam, few weeks after
surgery, where it is possible to
observe an ELMSI involving the
first metatarsal head (arrow in a)
compatible with the post-surgery
(iatrogenic) ELMSI; no ELMSI
of the tarsal bones (b). After 6
months, the patient continued to
feel pain in the left foot and MRI
was repeated. MRI shows the al-
most total remission of the ELM
in the surgical site (arrow in c),
confirming the alteration was a
simple post-surgery (iatrogenic)
ELMSI, but its presence with
“patchy” distribution in the cune-
iform bones, in the cuboid, in the
talus, in the calcaneus, associated
with effusion in the tarsal and an-
kle joints (d), led to the diagnosis
of CRPS
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in the metacarpophalangeal or proximal interphalangeal
joints. However, it cannot be detected in all patients with early
RA: literature reports that ELM is present in 40% of cases of
early RA (< 3 years’ duration) and in 70% of cases of
established RA (> 3 years’ duration) [87]. The clinical distinc-
tion between spondyloarthropathies involving peripheral
joints and RA is not so simple (for example, in psoriatic ar-
thritis “sine psoriasis”) (Fig. 9) and traditional radiography is
often not conclusive. Although clinical manifestations, sero-
logical and antibody biomarkers, radiography and ultrasound
are sensitive and specific tools for differential diagnosis, MRI
is useful for cases that remain uncertain. Its role in
distinguishing the various arthritis types, it has been much
debated over the years and various authors reported that
MRI is not able to distinguish among these entities at the
individual case level, although differences at the group level
are evident [88]. Some findings may therefore be useful, such
as a diffuse ELMSI adjacent to the enthesis, as well as florid
inflammatory soft tissue changes at this site, which represents
a clear sign of enthesitis, considered the hallmark of the pe-
ripheral forms of spondyloarthropathy. Another MRI finding
of psoriatic arthritis is the ELMSI observed in the diaphysis of
the phalanges at a considerable distance from the subchondral
bone and the capsular joint entheses. Instead, in patients with
RA, it usually occurs adjacent to cartilage in the subchondral
bone and is less extensive than in patients with
spondyloarthropathies [87].
Ischemic This category is represented by ELMSI caused by
AVN, a generic disease that may have different predisposing
conditions; it is more frequently found in younger patients
than SIFK and is related to different predisposing conditions
(sickle cell anemia, myeloproliferative disorders, alcohol, cor-
ticosteroids, and tobacco consumption) (Fig. 10). AVN pa-
tients experience pain (with a gradual onset) localized in the
joint district affected and sometimes the pain involves multi-
ple districts since AVN may interest multiple joints. In the
knee, the femoral condyles are the most involved, but in about
20% of cases, the tibial plateau may also be affected [89]. In
an early phase, AVN presents with a medullary necrotic area
delineated by a hypointense sclerotic rim representing the bor-
der between necrotic and vital bone that surrounds the infarct-
ed area without interruption. Often, in T2w sequences, an
inner high SI band, given by the granulation tissue, and an
outer low SI band, given by the bone sclerosis, are visible;
these two bands form the so-called “double-line sign.” In re-
cent years, many scientists have questioned the role of ELMSI
within AVN disease. In AVN of the femoral head, several
authors have observed that ELMSI does not represent an early
finding, as it is a secondary to a subchondral fracture. ELMSI
Fig. 8 a, b, c, d Inflammatory. A
56-year-old rheumatoid arthritis
(RA) male patient with pain and
swelling in the left wrist. TWIST
Angio 3D MIP imaging (a) clear-
ly shows the inflammation with
hypervascularization and edema
(arrowheads) affecting the left
wrist. Contrast-enhanced T1w
imaging (b) demonstrates an
abundant intra-articular effusion
in the distal radioulnar joint (*)
with thickening and enhancement
of synovia (arrow), a condition
referable to inflammation in the
active phase. STIR coronal imag-
ing (c) highlights the ELMSI af-
fecting part of the ulna, lunate,
triquetrum, hamate and capitate
bones, and the effusion in
radioscaphoid and radioulnar
joints. Finally, the X-rays of the
hand (d) taken at the same time
shows a “soft-tissue sign” near the
ulnar styloid process (arrow). but
absence of erosions, while MRI is
strongly positive for active
inflammation [courtesy of




in AVN correlates highly to the subsequent collapse of the
femoral head, resulting in clinical worsening of hip pain.
The occurrence of a subchondral fracture in AVN defines
stage 3 ARCO (Association for Research on Osseous
Circulation) and makes conservative treatment of the disease
impossible. For this reason, the detection of ELMSI in AVN
of the femoral head must lead to a careful search for a fracture
rim. If MRI fails to detect it, it is advisable to perform a CT
which is more sensitive. If the fracture is confirmed, joint
replacement or bone grafting is suggested. ELMSI in AVN
of the femoral head may represent an inflammatory change in
the reactive process during the progression of collapse of the
femoral head and might be a sign for the deterioration of the
disease [90].
Infectious ELMSI can be associated with bone infections such
as spondylodiscitis (Fig. 11) or osteomyelitis, and articular
infections (infectious arthritis). Bone infections can be divided
in exudative and necrotic forms. In the latter, ELMSI is caused
by an ischemic mechanism, while the exudative form is in-
duced by artero-capillary congestion, and, in this case, it is
important to differentiate (via history and/or bone marrow
aspiration) ELMSI from the gelatinous transformation of bone
marrow, a typical sign in patients with severe malnutrition and
protein loss. MRI commonly shows a mass of infected tissue
surrounded by a variable volume of ELMSI. Septic arthritis
has a wide spectrum of imaging presentation: sometimes it
appears with a full panel of signs as ELMSI with concomitant
changes in the cartilage, joint capsule, and soft tissues.
However, it could appear also with only one sign and with
small expressivity. Regardless of the imaging presentation,
during treatment, clinical symptoms usually regress faster than
the appearance of ELMSI on MRI, and it has been noted that
MRI findings can be of assistance in determining when to
cease treatment [58].
NeoplasticA great variety of benign and malignant neoplasms
can determine ELMSI. Usually, benign lesions, such as oste-
oid osteoma (Fig. 12) and osteoblastoma (Fig. 13), show an
important amount of surrounding marrow alterations [91].
Malignancy, represented by metastases and malignant prima-
ry bone tumors such as osteosarcoma (Fig. 13), Ewing’s sar-
coma, and chondrosarcoma induce a minor quantity of
ELMSI, except for chondroblastoma and Langerhans’s cell
histiocytosis. The ELMSI associated with osteoid osteoma
(present in more than 60% of patients) is probably caused by
tumor-associated inflammatory mediators (including prosta-
glandin E2), while the one related to other tumors is thought
to be caused by trabecular destruction and local inflammation
[58]. Differentiating between the neoplastic mass and the
Fig. 9 a, b, c, d Inflammatory. A
49-year-old woman with swelling
and pain in the left
sternoclavicular joint and history
of psoriasis. MRI highlights the
ELMSI of the joint (arrows),
which is hyperintense in STIR (a–
c) and hypointense in T1w (b–d)
imaging. This is a very particular
condition and can be referred to
either an early SAPHO (synovi-
tis-acne-pustulosis-hyperostosis-
osteitis) syndrome, which is often
connected with a special form of
psoriasis (pustulosis
palmoplantaris) and has an in-
flammatory involvement of the
sternoclavicular joint, or a Tietze
syndrome, a painful inflammation




ELMSI is crucial for the orthopedic surgeon and so, to do this
task appropriately, radiologists can be helped by DwI and
chemical shift–weighted imaging sequences [58].
Iatrogenic It can derive from local surgery (Fig. 7), radiother-
apy or the use of some drugs such as calcineurin inhibitors
[58]. It occurs most frequently post radiotherapy and in this
context it is thought to be a relatively rapid change that takes
place acutely (1–14-day time frame) (Fig. 14). Even if some
authors did not detect ELMSI beyond 21 days post-
radiotherapy [92], its presence, intensity, and duration can
vary significantly depending on the type and location of the
treatment.
Metabolic Irrespective of the presence of cortical erosion,
ELMSI at the insertion site of the pathologic tendon is asso-
ciated with the inflammatory response tomicroscopic deposits
of hydroxyapatite within the bone. Another tendinopathy
linked to the presence of abundant ELMSI is represented by
calcium pyrophosphate deposition (CPPD), especially in the
acute phase [93]. Less frequently, ELMSI can be caused by
the presence of intraosseous tophi in patients with gout [58].
Fig. 10 a, b, c, d, e, f, g, h AVN. A 53-year-old woman with pain during
mobilization of the right knee; MRI has raised the suspicion of AVN
(bone infarct) and we can note the evolution of the findings over 4 years.
T1w (a) and proton density fat–suppressed (PD-FS, b) imaging show two
areas of altered signal in the distal end of the femur and in the proximal
end of the tibia with irregular morphology and inhomogeneous structure
(*), with a peripheral rim, hypointense in T1w (arrows) and hyperintense
in PD-FS (arrows) imaging corresponding to the reactive interface along
the margin of infarct. Three months after the previousMRI (c, T1w and d,
PD-FS), a further increase in the interface (arrows), a reduction in the
ischemic area and signs of regeneration of the cancellous bone are
observed. While the MRI findings are well evident, the CT performed
in the same period (e) shows only a limited rarefaction (*) of the cancel-
lous bone. One year later (f, T2w-FS) the infarct outcome area is still
evident but smaller compared to previous examinations. Four years later
(g, PD and h, STIR) the infarct zone appears less extensive and more
shaded, but still present; the interface appears larger. ELMSI had not been
detected for all 4 years and the patient progressively underwent an im-
provement in the clinical situation, with the disappearance of the pain. It is
important to underline that ELMSI represents a fundamental indicator of
a subchondral fracture and a progression towards epiphyseal collapse,
which in this case did not occur
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Neurological Charcot’s joint is a progressive degenerative,
inflammatory, and destructive joint disease with abnormal
pain sensation and proprioception. ELMSI is often associated
with this disorder, due to the polyneuropathy caused by dia-
betes mellitus; the most commonly joints affected are foot and
ankle [94]. Even if conventional X-rays acquisitions are tradi-
tionally the standard imaging technique for diagnosing, stag-
ing, and monitoring the disease, MRI can be very sensitive to
obtain an early diagnosis and determine the course of the
healing process. In fact, ELMSI is an early sign of Charcot’s
joint and until when a significant amount is seen on MRI;
consequently, off-loading therapy (with removable total con-
tact casts) must be continued. Only when a significant de-
crease or complete disappearance is detected, the cast can be
removed, and an orthopedic shoe adapted [94, 95].
Differentiation between acute Charcot foot and infection
(osteomyelitis) is not so simple because clinical exam and
X-rays acquisitions may be not conclusive. However, differ-
entiation is important because treatment varies depending on
the disease present and MRI can be very helpful. In osteomy-
elitis, ELMSI tends to be extensive and usually involving a
single bone, while it tends to be periarticular and subchondral
in acute Charcot osteoarthropathy. Moreover, a focal involve-
ment of the weight-bearing surfaces of the toes or the meta-
tarsal heads, absence of deformity, presence of sinus tract, and
soft tissue infection are suggestive of osteomyelitis, while an
involvement of several joints/bones, deformity along with
bone debr is usual ly present wi th acute Charcot
osteoarthropathy [96].
Fig. 11 a, b, c, d Infectious.
Spondylodiscitis involving L4–
L5 in a 52-year-old man with fe-
ver and low back pain. MRI
shows a large ELMSI (*) of the
vertebral bodies, appearing
hypointense in T1w imaging (a),
hyperintense in T2w (b), STIR
(c), and contrast-enhanced T1w
imaging (d). The interposed disc
is also involved in the inflamma-
tory process, appearing hyperin-
tense on T2w, STIR and contrast-
enhanced T1w sequences
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Fig. 13 a, b, c, d Benign and
malignant neoplastic. ELMSI
from an osteoblastoma of the left
hemisoma of S1 in a 36-year-old
male patient (a–b). STIR coronal
image (a) allows to detect an ex-
tensive ELMSI (*) involving the
left hemisomas of S1 and S2 and
the left posterior-lower corner of
L5 (arrowhead). In STIR axial
image (b) we can see both the
ELMSI (*) and the benign nodule
of S1 (arrowheads). Marrow al-
terations from a periosteal osteo-
sarcoma of the proximal diaphy-
sis of the right femur in a 74-year-
old woman (c–d). STIR coronal
image (c) shows the exophytic
development of the tumor (arrow)
and the extensive edemigenous
reaction of the femoral spongiosa
(arrowheads); in d, T1w image,
on the axial plane, we can see the
tumor (arrows) and the
hypointense ELMSI (*) occupy-
ing the entire medullary canal
Fig. 12 a, b, c Benign neoplastic (osteoid osteoma). A 8-year-old male
patient with pain in the end of the left thigh worsening at night. T1w
imaging (a) shows a hypointense lesion with well-defined margins
(arrowhead) surrounded by a slightly hypointense halo (*). STIR imag-
ing (b) demonstrates the edematous nature of the halo (*) and well
highlights the great extension of the perilesional ELMSI itself.
Contrast-enhanced T1w imaging (c) shows the enhancement of the nidus




The old term “bone marrow edema” is nowadays replaced by
“ELMSI,” an acronym indicating the well-known MR T2w
hyperintense marrow areas that can be caused not only by a
simple real edema, but by various occurrences, such as lym-
phocytic infiltrates, early fibrosis, necrosis, hemorrhage, and
aggregates of bone vessels. ELMSI is not always a patholog-
ical finding and may be observed, for example, in healthy
children knee, where it is generally a transitory, self-limiting
condition related to growth plate closure. ELMSI presents a
dynamic behavior and its evolution can largely vary; MRI can
track its changes over time, becoming a marker to follow the
evolution and therapeutic response of the underlying disease.
Unenhanced MR can easily detect ELMSI and help in clari-
fying its cause. However, particularly when the cause is un-
known, it can be difficult to predict if an ELMSI area will
completely resolve or progress towards osteonecrosis, and in
order to solve this problem, perfusion studies are ongoing with
promising preliminary results.
In conclusion, ELMSI proved to be a very interesting topic
and deserves to be explored further.
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